Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Morgan

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Gynecologic Oncology|December 26, 2001
The clinical course of deep vein thrombosis in patients with gynecologic cancerMark A Morgan, Tara D Iyengar, Beata E Napiorkowski, et al.
The Australian Journal of Rural Health|July 26, 2008
Depression in acute coronary syndrome: has the evidence been implemented?Prasuna Reddy, James A Dunbar, Adrienne O'Neil, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2017
Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T CellsJanos L Tanyi, Caitlin Stashwick, Gabriela Plesa, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 18, 2020
Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovaryDimitrios Nasioudis, Spyridon A Mastroyannis, Ashley F Haggerty, et al.
American Journal of Obstetrics and Gynecology|January 27, 2005
A new questionnaire for urinary incontinence diagnosis in women: development and testingCatherine S Bradley, Eric S Rovner, Mark A Morgan, et al.
Gynecologic Oncology Reports|April 13, 2019
Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?Dimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
American Journal of Obstetrics and Gynecology|November 1, 2020
Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size ≤2 cmDimitrios Nasioudis, Benjamin B Albright, Ashley F Haggerty, et al.
Gynecologic Oncology|June 4, 2019
Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinomaDimitrios Nasioudis, Ashley F Haggerty, Robert L Giuntoli, et al.
Gynecologic Oncology Reports|June 14, 2019
Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumorsDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Gynecologic Oncology|December 12, 2022
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinomaDimitrios Nasioudis, Nawar A Latif, Emily M Ko, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|December 26, 2001
The clinical course of deep vein thrombosis in patients with gynecologic cancerMark A Morgan, Tara D Iyengar, Beata E Napiorkowski, et al.
The Australian Journal of Rural Health|July 26, 2008
Depression in acute coronary syndrome: has the evidence been implemented?Prasuna Reddy, James A Dunbar, Adrienne O'Neil, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2017
Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T CellsJanos L Tanyi, Caitlin Stashwick, Gabriela Plesa, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 18, 2020
Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovaryDimitrios Nasioudis, Spyridon A Mastroyannis, Ashley F Haggerty, et al.
American Journal of Obstetrics and Gynecology|January 27, 2005
A new questionnaire for urinary incontinence diagnosis in women: development and testingCatherine S Bradley, Eric S Rovner, Mark A Morgan, et al.
Gynecologic Oncology Reports|April 13, 2019
Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?Dimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
American Journal of Obstetrics and Gynecology|November 1, 2020
Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size ≤2 cmDimitrios Nasioudis, Benjamin B Albright, Ashley F Haggerty, et al.
Gynecologic Oncology|June 4, 2019
Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinomaDimitrios Nasioudis, Ashley F Haggerty, Robert L Giuntoli, et al.
Gynecologic Oncology Reports|June 14, 2019
Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumorsDimitrios Nasioudis, Emily M Ko, Ashley F Haggerty, et al.
Gynecologic Oncology|December 12, 2022
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinomaDimitrios Nasioudis, Nawar A Latif, Emily M Ko, et al.
Pageof 9